Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ag85B is a major secreted protein of Mycobacterium tuberculosis and part of the antigen 85 (Ag85) complex. It functions as a mycolyl transferase, catalyzing transesterification reactions essential for the biosynthesis of key cell wall components like TMM and TDM. It is crucial for bacterial survival and considered a leading drug target for new antituberculous therapies. Ag85B is also highly immunogenic and a component in several candidate TB vaccines.
Inhibition of mycolyl transferase activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ag85B protein.